Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1990-09-10
1992-06-09
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514 16, 514401, A61K 3700
Patent
active
051207133
ABSTRACT:
Obese patients may be effectively treated by cojointly administering an alpha-2-adrenergic agonist, such as clonidine, and a growth hormone releasing peptide, such as GHRH, to restore or substantially enhance growth hormone release in such patients.
REFERENCES:
patent: 4224316 (1980-09-01), Momany
patent: 4910214 (1990-03-01), Karjalainen et al.
patent: 4910215 (1990-03-01), Muller
Williams, N. Engl. J. Med. 311:1403, 1984.
Kopelman, Clin. Endocrinol. 23:87, 1985.
Kopelman, Clin. Endocrinol. 24:157, 1986.
Loche, Clin. Endocrinol. 27:145, 1987.
Cordido, J. Clin. Endocrinol. Metab., 68:290, 1989.
Ghigo, J. Endocrinol Invest. 12:99, 1989.
Davis, J. Clin. Endocrinol. Metab. 65:1248, 1987.
Chatterjee, J. Endocrinol. 116:R1-R2, 1988.
Reiter, J. Pediat. Endocrinol. 3:21, 1988.
Arce, Neuroendocrinology 52/S1/90:119, 1990, Poster 3.50 of 2nd Int'l Cong. of Neuroendocrinology held Jun. 24-29, 1990.
Ghigo, "Effects of the Enhancement of the Cholinergic Activity on Growth Hormone Secretion in Children: Clinical Implications", Recent Advances in Basic and Clinical Neuroendocrinology (eds. Casanueva and Dieguez), pp. 241-251, 1989, Excerpta Medica, Amsterdam.
Cordido et al., Chem. Abstracts 113:453 (Jul. 1990), abstract 21676S.
Applied Research Systems ARS Holding N.V.
Cashion Jr. Merrell C.
Koh Choon
Williams Stephan P.
LandOfFree
Treatment of obesity with an alpha-2-adrenergic agonist and a gr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of obesity with an alpha-2-adrenergic agonist and a gr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of obesity with an alpha-2-adrenergic agonist and a gr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1804497